Denali Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Denali Therapeutics Inc. has filed 775 SEC EDGAR filings since 08 Sep 2017

SEC filing history

Showing 176-200 of 775 matching filings.

Per page
25
Current page
8
DEFA14A File 001-38311

DEFA14A

Filing date
18 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38311

DEF 14A

Filing date
18 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
4

FORM 4

Filing date
17 Apr 2024
Reporting date
15 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
15 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Apr 2024
Reporting date
01 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
01 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Mar 2024
Reporting date
29 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-278174

S-3ASR

Filing date
22 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2024
Reporting date
15 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-506551

D filing

Filing date
01 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-277429

S-8

Filing date
28 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Feb 2024
Reporting date
15 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38311

144 filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .